Epsilon M&A Deal Report - Altan Pharma
Transaction Multiples for the Valuation of Private Companies
Ethypharm / Altan Pharma
No EMAT :
109827
Announced Date :
18/06/2021
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Ethypharm
Target :
Altan Pharma
Country :
Ireland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Altan Pharma is a specialty pharmaceutical company that develops, manufactures and markets injectable medications for the hospital and other provider segments. > Markets a portfolio of over 40...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | ns | ns | |||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/11/2021 | Medios | NewCo Pharma Group | Germany | ** | 109809 |
| 30/09/2020 | DomusVi | La Barillière | Calvados | *** | 109797 |
Source: Epsilon Research / EMAT
